Narges Khaghanzadeh

Umbelliprenin is cytotoxic against QU-DB large cell lung cancer cell line but anti-proliferative against A549 adenocarcinoma cells

Narges Khaghanzadeh, Zahra Mojtahedi, Mohammad Ramezani et al. · DARU Journal of Pharmaceutical Sciences · 2012 · 39 citations · Full text

Medicine, Oncology, Pharmacology +4

CTLA4 gene variations and haplotypes in patients with lung cancer

Narges Khaghanzadeh, Nasrollah Erfani, Seiyed Mohammad Ali Ghayumi et al. · Cancer Genetics and Cytogenetics · 2009 · 31 citations

Life Sciences, Genetics, Oncology +13

Umbelliprenin induced production of IFN-<b>γ</b>and TNF-<b>α</b>, and reduced IL-10, IL-4, Foxp3 and TGF-<b>β</b>in a mouse model of lung cancer

Narges Khaghanzadeh, Afshin Samiei, Mohammad Ramezani et al. · Immunopharmacology and Immunotoxicology · 2013 · 28 citations

Medicine, Immunology, Pharmacology +16

PDCD1, CTLA-4 and p53 gene polymorphism and susceptibility to gestational trophoblastic diseases.

Alamtaj Samsami Dehaghani, Mohammad Amin Kashef, Mehdi Ghaemenia et al. · PubMed · 2009 · 13 citations

Medicine, Genetics, Molecular Genetics +17

Umbelliprenin induced both anti-inflammatory and regulatory cytokines in C57/BL6 mice.

Narges Khaghanzadeh, Afshin Samiei, Zahra Mojtahedi et al. · PubMed · 2017 · 10 citations

Life Sciences, Immunology, Pharmacology +17